Avantor, Inc. (AVTR)
17.29
+0.14
(+0.82%)
USD |
NYSE |
Oct 23, 16:00
17.29
0.00 (0.00%)
After-Hours: 20:00
Avantor Enterprise Value : 15.09B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 15.09B |
| October 22, 2026 | 14.99B |
| October 21, 2026 | 15.07B |
| October 20, 2026 | 14.63B |
| October 19, 2026 | 14.41B |
| October 16, 2026 | 14.50B |
| October 15, 2026 | 14.28B |
| October 14, 2026 | 14.01B |
| October 13, 2026 | 13.91B |
| October 12, 2026 | 13.87B |
| October 09, 2026 | 13.99B |
| October 08, 2026 | 13.80B |
| October 07, 2026 | 13.78B |
| October 06, 2026 | 13.83B |
| October 05, 2026 | 14.09B |
| October 02, 2026 | 13.77B |
| October 01, 2026 | 13.56B |
| September 30, 2026 | 13.57B |
| September 29, 2026 | 13.70B |
| September 28, 2026 | 13.73B |
| September 25, 2026 | 13.71B |
| September 24, 2026 | 13.80B |
| September 23, 2026 | 13.38B |
| September 22, 2026 | 13.50B |
| September 21, 2026 | 13.61B |
| Date | Value |
|---|---|
| September 18, 2026 | 13.89B |
| September 17, 2026 | 14.12B |
| September 16, 2026 | 13.95B |
| September 15, 2026 | 13.84B |
| September 14, 2026 | 13.65B |
| September 11, 2026 | 13.41B |
| September 10, 2026 | 13.46B |
| September 09, 2026 | 13.46B |
| September 08, 2026 | 13.71B |
| September 04, 2026 | 13.52B |
| September 03, 2026 | 13.67B |
| September 02, 2026 | 13.30B |
| September 01, 2026 | 13.00B |
| August 31, 2026 | 13.23B |
| August 28, 2026 | 13.25B |
| August 27, 2026 | 13.27B |
| August 26, 2026 | 13.20B |
| August 25, 2026 | 13.15B |
| August 24, 2026 | 13.04B |
| August 21, 2026 | 13.17B |
| August 20, 2026 | 13.03B |
| August 19, 2026 | 12.83B |
| August 18, 2026 | 12.41B |
| August 17, 2026 | 12.52B |
| August 14, 2026 | 12.63B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Champions Oncology, Inc. | 72.87M |
| Medpace Holdings, Inc. | 18.13B |
| Personalis, Inc. | 1.511B |
| Adaptive Biotechnologies Corp. | 4.132B |
| 10X Genomics, Inc. | 8.848B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 38.10M |
| Revenue (Quarterly) | 1.692B |
| Total Expenses (Quarterly) | 1.654B |
| EPS Diluted (Quarterly) | 0.0563 |
| Gross Profit Margin (Quarterly) | 31.73% |
| Profit Margin (Quarterly) | 2.25% |
| Earnings Yield | -4.90% |
| Operating Earnings Yield | 4.59% |
| Normalized Earnings Yield | 0.0486 |